PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromE

A phase 2 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 243 participants.

Also called NCT04601467

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 243 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04601467
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
New Zealand, Singapore (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT04601467. Randomized; triple masking; primary purpose treatment. Start 2021-07-12 (actual); primary completion 2024-05-27 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromE
Acronym
PASSIVATE
Condition
Acute Coronary Syndrome
Intervention (Drug)
AZD5718
Intervention (Drug)
Placebo
Lead sponsor
National University Heart Centre, Singapore (class: other)
Collaborator
AstraZeneca (class: industry)
Collaborator
University of Otago (class: other)

Record details

Record id
cardio:ct-nct04601467
Content hash
9615d99d52380dd44ce760890ebf8a4e4d91f337d0511bde959cfb887d6967b7